Who Should Perform VAD Destination Therapy? CMS Proposes Changes
This article was originally published in The Gray Sheet
Executive Summary
CMS issued a proposed national coverage decision 1memo Dec. 27 that would revise the medical facility criteria for implanting ventricular assist devices for extended support of patients ineligible for a heart transplant
You may also be interested in...
CMS Eases Volume Rules For Ventricular Assist Device Implant Facilities
CMS finalized its proposal to relax the implant volume standard for medical facilities implanting ventricular assist devices for extended support of patients ineligible for a heart transplant
CMS Eases Volume Rules For Ventricular Assist Device Implant Facilities
CMS finalized its proposal to relax the implant volume standard for medical facilities implanting ventricular assist devices for extended support of patients ineligible for a heart transplant
Thoratec, Abiomed, ACC Comment On CMS Revision Of VAD Coverage Policy
Ventricular assist device maker Thoratec is hesitant to support a procedure-experience threshold as a criterion for CMS clearance of facilities implanting VADs for destination therapy